Related Experiment Video
Updated: Jul 12, 2026
03:23
Three-Dimensional Cell Culture Models to Investigate the Epithelial Barrier in Eosinophilic Esophagitis
Published on: May 10, 2024
Eosinophil diversity and function: emerging insights into subtypes and therapeutic targets
Faiz Ali Khan1,2, Abhishek Raj1,2, Hizbullah Khan3
1Institutes of Integrative Medicine, Fudan University, Shanghai, China.
Cell Death Discovery
|July 10, 2026
Summary
Eosinophils, immune cells historically known for allergies and parasite defense, are now recognized as diverse subtypes. Understanding this eosinophil heterogeneity is key for developing targeted therapies for eosinophil-associated disorders.
Area of Science:
- Immunology
- Cell Biology
- Medical Science
Background:
- Eosinophils are immune cells involved in allergic responses and parasitic infections.
- Recent research links eosinophils to various eosinophil-associated disorders.
- Eosinophil heterogeneity, with distinct resident (rEos) and inflammatory (iEos) subtypes, is now recognized in humans and murine models.
Purpose of the Study:
- To review recent discoveries in eosinophil diversity.
- To explore the therapeutic implications of targeting specific eosinophil subsets.
Main Methods:
- Literature review of recent immunological and molecular biology research.
- Analysis of studies on eosinophil heterogeneity in human and murine models.
- Examination of current and emerging targeted biologic therapies for eosinophil-associated disorders.
Main Results:
- Eosinophils exhibit significant heterogeneity, with distinct functional properties and tissue localization.
- Resident eosinophils (rEos) are involved in tissue maintenance, while inflammatory eosinophils (iEos) drive acute inflammation.
- Advances in understanding eosinophil subsets offer potential for more precise therapeutic strategies.
Conclusions:
- Recognizing distinct eosinophil subsets is crucial for understanding disease pathogenesis.
- Targeting specific eosinophil subsets holds promise for improved treatment outcomes in eosinophilic disorders.
- Further research into eosinophil heterogeneity will refine therapeutic approaches.
Related Concept Videos
01:11Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase
Genetic polymorphisms in drug targets have emerged as critical determinants of interindividual variability in drug response and toxicity. Pharmacogenomic investigations increasingly focus on identifying these variations to personalize and optimize therapeutic interventions. A drug target may be a receptor, enzyme, or signaling protein involved in pharmacologic responses or disease-related pathways. While early pharmacogenetic studies focused primarily on drug metabolism, current research...
01:25Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs
Asthma is a chronic respiratory condition for which new therapeutic avenues, including anti-inflammatory drugs like mast cell stabilizers and anti-IgE treatments, continue to be developed.
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
01:26Asthma-II: Pathophysiology and Classification
Asthma is a prevalent chronic respiratory condition marked by inflammation and hyperresponsiveness of the airways. Its pathophysiology involves complex interactions among inflammatory pathways, immune responses, and neural mechanisms.
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
01:28Asthma I: Introduction
Asthma is a chronic inflammatory disorder of the airways characterized by variable airflow obstruction and heightened bronchial responsiveness to a wide range of triggers. The underlying inflammation leads to airway swelling, mucus hypersecretion, and smooth muscle constriction, all of which narrow the airway lumen and impede airflow. Clinically, asthma presents with recurrent episodes of wheezing, shortness of breath, chest tightness, and coughing, symptoms that typically vary in intensity and...
01:21EPS and iPS Cells in Disease Research
Embryonic and induced pluripotent stem cells are excellent models for disease research because of their ability to self-renew and differentiate into most cell types. Somatic cells from a patient are isolated and reprogrammed into induced pluripotent stem cells or iPSCs. These iPSCs are later differentiated into the desired cell type, which mirrors the diseased cell of the patient. In this way, disease models have been created for investigating diseases such as Down syndrome, type I diabetes,...
01:25Dose-Response Relationship: Selectivity and Specificity
Drugs exert their therapeutic effects by interacting with receptors, enzymes, or ion channels that are present throughout the human body. The strength and duration of the interaction between a drug and its target receptor are characterized by the selectivity and specificity of the drug. Selectivity refers to a drug's strong preference for its intended target over other targets. For instance, isoprenaline, a non-selective β-adrenergic agonist, interacts with both β1- and β2-adrenergic receptors...